Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2022 08:24 ET | Source: SERB Pharmaceuticals

SERB presents preclinical data showing initial efficacy of COVID-19 treatment developed with polyclonal antibody platform

Washington D.C., Oct. 19, 2022 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals today announces preclinical data demonstrating initial efficacy of a new polyclonal, ovine fragment antibody (Fab) developed...